Posted by Michael Wonder on 02 Aug 2024
Nordimet (methotrexate) self-injection pen now available in Canada for treatment of rheumatoid arthritis and psoriasis/psoriatic arthritis
1 August 2024 - Linepharma is pleased to announce that Nordimet (methotrexate), the first methotrexate single-use pre-filled pen for self-injection, is now available in Canada for the treatment of adult patients with:
- Severe disabling active rheumatoid arthritis
- Severe disabling psoriasis/psoriatic arthritis, specifically for cases that are recalcitrant and have not responded adequately to other therapies, following a dermatologic consultation.
Nordimet is distributed in Canada by Linepharma, a subsidiary of Nordic Group.
